A Study of Anti-PD-1 (Pembrolizumab) Therapy in Metastatic Melanoma (ADAPTeM)
Clinical trial NCT02663258 · WITHDRAWN
Trial details
- NCT number
- NCT02663258
- Sponsor
- Royal Marsden NHS Foundation Trust
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2017-07-19
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.